Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ChemoCentryx Stock Forecast NASDAQ:CCXI
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-06 | 352.8% | Raymond James | $110.00 $106.00 | Maintains | Strong Buy |
| 2021-11-10 | 369.88% | Raymond James | $107.00 $110.00 | Maintains | Strong Buy |
| 2021-10-11 | 62.32% | JP Morgan | $14.00 $38.00 | Upgrades | Underweight Neutral |
| 2021-10-11 | 357.07% | Raymond James | $62.00 $107.00 | Upgrades | Outperform Strong Buy |
| 2021-10-11 | 173.39% | SVB Leerink | $17.00 $64.00 | Upgrades | Market Perform Outperform |
| 2021-10-08 | 357.07% | Raymond James | $62.00 $107.00 | Upgrades | Outperform Strong Buy |
| 2021-07-07 | 32.42% | Stifel | $26.00 $31.00 | Upgrades | Hold Buy |
| 2021-05-07 | -27.38% | SVB Leerink | $84.00 $17.00 | Downgrades | Outperform Market Perform |
| 2021-05-07 | 6.79% | Piper Sandler | $80.00 $25.00 | Downgrades | Overweight Neutral |
| 2021-05-07 | -27.38% | JP Morgan | $57.00 $17.00 | Downgrades | Neutral Underweight |
| 2021-05-07 | 11.06% | Stifel | $93.00 $26.00 | Downgrades | Buy Hold |
| 2021-05-07 | 117.86% | Raymond James | $120.00 $51.00 | Downgrades | Strong Buy Outperform |
| 2021-05-07 | 19.61% | HC Wainwright & Co. | $101.00 $28.00 | Maintains | Buy |
| 2021-03-02 | 412.6% | Raymond James | $119.00 $120.00 | Maintains | Strong Buy |
| 2021-03-02 | 297.27% | Stifel | $93.00 | Initiates Coverage On | Buy |
| 2021-01-08 | 408.33% | Raymond James | $100.00 $119.00 | Maintains | Strong Buy |
| 2020-10-29 | 199.02% | Wells Fargo | $79.00 $70.00 | Maintains | Overweight |
| 2020-10-29 | 258.82% | SVB Leerink | $75.00 $84.00 | Maintains | Outperform |
| 2020-10-29 | 156.3% | JP Morgan | $63.00 $60.00 | Downgrades | Overweight Neutral |
| 2020-10-29 | 203.29% | Piper Sandler | $67.00 $71.00 | Maintains | Overweight |
| 2020-08-11 | 327.17% | Raymond James | $95.00 $100.00 | Maintains | Strong Buy |
| 2020-07-29 | 160.57% | JP Morgan | $64.00 $61.00 | Maintains | Overweight |
| 2020-06-17 | 199.02% | BTIG | $70.00 | Initiates Coverage On | Buy |
| 2020-05-27 | 237.46% | Wells Fargo | $79.00 | Initiates Coverage On | Overweight |
| 2020-05-19 | 147.76% | Canaccord Genuity | $68.00 $58.00 | Maintains | Buy |
| 2020-05-14 | 173.39% | JP Morgan | $61.00 $64.00 | Maintains | Overweight |
| 2020-05-12 | 190.47% | Canaccord Genuity | $64.00 $68.00 | Maintains | Buy |
| 2020-05-12 | 335.71% | Raymond James | $38.00 $102.00 | Reiterates | Strong Buy |
| 2020-05-12 | 177.66% | SVB Leerink | $54.00 $65.00 | Reiterates | Outperform |
| 2020-03-11 | 160.57% | JP Morgan | $60.00 $61.00 | Maintains | Overweight |
| 2020-03-11 | 173.39% | Raymond James | $56.00 $64.00 | Maintains | Strong Buy |
| 2020-02-18 | 156.3% | JP Morgan | $28.00 $60.00 | Maintains | Overweight |
| 2020-01-24 | 156.3% | HC Wainwright & Co. | $40.00 $60.00 | Maintains | Buy |
| 2019-11-26 | 105.04% | Canaccord Genuity | $16.00 $48.00 | Maintains | Buy |
| 2019-11-26 | 139.21% | Raymond James | $17.00 $56.00 | Maintains | Strong Buy |
| 2019-09-12 | -40.2% | JP Morgan | $16.00 $14.00 | Upgrades | Neutral Overweight |
| 2019-06-06 | -27.38% | Raymond James | $24.00 $17.00 | Maintains | Strong Buy |
CCXI Stock Trend
Given the current short-term trend, the stock is expected to fall -23.97% during the next 3 months and, with a 90% probability hold a price between $10.43 and $17.80 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-06-01 | $13.60 | $18.45 | $23.29 |
| 2022-06-02 | $13.49 | $18.33 | $23.18 |
| 2022-06-03 | $13.37 | $18.21 | $23.06 |
| 2022-06-06 | $13.25 | $18.10 | $22.94 |
| 2022-06-07 | $13.13 | $17.98 | $22.82 |
| 2022-06-08 | $13.02 | $17.86 | $22.71 |
| 2022-06-09 | $12.90 | $17.74 | $22.59 |
| 2022-06-10 | $12.78 | $17.63 | $22.47 |
| 2022-06-13 | $12.67 | $17.51 | $22.36 |
| 2022-06-14 | $12.55 | $17.39 | $22.24 |
| 2022-06-15 | $12.43 | $17.28 | $22.12 |
| 2022-06-16 | $12.31 | $17.16 | $22.00 |
| 2022-06-17 | $12.20 | $17.04 | $21.89 |
| 2022-06-21 | $12.08 | $16.92 | $21.77 |
| 2022-06-22 | $11.96 | $16.81 | $21.65 |
| 2022-06-23 | $11.85 | $16.69 | $21.54 |
| 2022-06-24 | $11.73 | $16.57 | $21.42 |
| 2022-06-27 | $11.61 | $16.46 | $21.30 |
| 2022-06-28 | $11.49 | $16.34 | $21.18 |
| 2022-06-29 | $11.38 | $16.22 | $21.07 |
| 2022-06-30 | $11.26 | $16.10 | $20.95 |
| 2022-07-01 | $11.14 | $15.99 | $20.83 |
| 2022-07-05 | $11.03 | $15.87 | $20.72 |
| 2022-07-06 | $10.91 | $15.75 | $20.60 |
| 2022-07-07 | $10.79 | $15.64 | $20.48 |
| 2022-07-08 | $10.67 | $15.52 | $20.36 |
| 2022-07-11 | $10.56 | $15.40 | $20.25 |
| 2022-07-12 | $10.44 | $15.28 | $20.13 |
| 2022-07-13 | $10.32 | $15.17 | $20.01 |
| 2022-07-14 | $10.21 | $15.05 | $19.90 |
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders, and cancer in the United States. Its lead drug candidates in clinical development include CCX168, which is in Phase II clinical trials for the treatment of orphan and rare diseases; CCX872, which is in Phase I... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
